- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 498/10 - Spiro-condensed systems
Patent holdings for IPC class C07D 498/10
Total number of patents in this class: 935
10-year publication summary
|
33
|
56
|
45
|
56
|
51
|
51
|
72
|
81
|
74
|
76
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Sharp & Dohme LLC | 3732 |
29 |
| Amgen Inc. | 4256 |
26 |
| Bristol-myers Squibb Company | 4826 |
24 |
| F. Hoffmann-La Roche AG | 7937 |
24 |
| Novartis AG | 10612 |
22 |
| Hoffmann-La Roche Inc. | 3546 |
22 |
| Boehringer Ingelheim International GmbH | 4636 |
22 |
| Janssen Pharmaceutica N.V. | 3358 |
21 |
| Vertex Pharmaceuticals Incorporated | 1630 |
18 |
| Arvinas Operations, Inc. | 244 |
18 |
| Merck Patent GmbH | 5752 |
16 |
| Pfizer Inc. | 3401 |
15 |
| AstraZeneca AB | 2857 |
12 |
| Daiichi Sankyo Company, Limited | 1879 |
12 |
| Nxera Pharma UK Limited | 175 |
12 |
| Takeda Pharmaceutical Company Limited | 2721 |
11 |
| Nurix Therapeutics, Inc. | 104 |
11 |
| Genentech, Inc. | 4016 |
10 |
| Glaxosmithkline Intellectual Property Development Limited | 779 |
10 |
| Teijin Limited | 1257 |
10 |
| Other owners | 590 |